Join
Live feed
·
INSIDERFilingvia Quantisnow
Reata Pharmaceuticals Inc. logo

SEC Form 4: Bir Dawn Carter converted options into 90,000 shares and sold $8,503,621 worth of shares (96,996 units at $87.67), decreasing direct ownership by 14% to 41,513 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RETA (Reata Pharmaceuticals Inc.) and more on Quantisnow.